Neo Ivy Capital Management’s QuidelOrtho QDEL Stock Holding History

Neo Ivy Capital Management’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-40,959	Closed	-$1.82M	–	400
2024 Q4	$1.82M	Buy	+40,959	New	+$1.68M	0.37%	113
2024 Q3	–	Sell	-376	Closed	-$12K	–	375
2024 Q2	$12K	Buy	+376	New	+$15.4K	﹤0.01%	216
2023 Q4	$0	Buy	+5	New	+$338	﹤0.01%	429
2022 Q4	$715K	Buy	+8,346	New	+$707K	0.48%	85
2022 Q2	–	Sell	-1,460	Closed	-$164K	–	577
2022 Q1	$164K	Buy	1,460 +948	+185%	+$101K	0.15%	232
2021 Q4	$69K	Buy	+512	New	+$71.3K	0.1%	256
2021 Q2	–	Sell	-784	Closed	-$100K	–	580
2021 Q1	$100K	Buy	784 +218	+39%	+$40.3K	0.11%	243
2020 Q4	$102K	Buy	566 +121	+27%	+$26.9K	0.11%	252
2020 Q3	$97K	Buy	+445	New	+$99.3K	0.1%	295

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Neo Ivy Capital Management's QDEL Position: Q1 2025 in Review

Neo Ivy Capital Management sold out of QuidelOrtho (QDEL) in Q1 2025, closing a stake of 40,959 shares — an estimated $1.82M sold.

Neo Ivy Capital Management first reported a position in QDEL in Q3 2020 and held it in 9 quarters. The position peaked at $1.82M in Q4 2024. 266 funds tracked by Wall St. Rank hold QDEL as of Q1 2025.

Neo Ivy Capital Management reported no remaining QuidelOrtho position as of Q1 2025 after selling out during the quarter.
Neo Ivy Capital Management sold 40,959 QuidelOrtho shares in Q1 2025, an estimated $1.82M.
Neo Ivy Capital Management first reported a position in QuidelOrtho in Q3 2020 and held it in 9 quarters.
Neo Ivy Capital Management's QuidelOrtho position peaked at $1.82M in Q4 2024.
266 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2025.

Based on Neo Ivy Capital Management's 13F filing for Q1 2025, filed 6 May 2025.